Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sea Limited (SE) vs 10X Genomics Inc (TXG) Price & Performance

Sea LimitedTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Sea Limited vs 10X Genomics Inc — how do they compare? Sea Limited trades at $106.26 (market cap $64.73B), while 10X Genomics Inc trades at $47.2 (market cap $5.48B). The key difference: Sea Limited is far larger — about 11.8× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.

SETXG
Market Cap
$64.73B$5.48B
Sector
MediaHealth
52-Week High
$196.50$45.80
52-Week Low
$78.16$11.34
Enterprise Value
$57.78B$5.02B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sea Limited

Sea Limited (SE) trades at $106.26, up 2.12% with a neutral technical signal. The company shows strong revenue growth, reaching $22.94 billion in 2025 with a net income margin of 6.36%. Recent earnings beat expectations in Q1 2026 but missed in prior quarters. Analyst sentiment remains bullish with a $131 consensus price target, though insider selling has drawn attention amid a 30% stock decline over the past year.

The outlook is mixed: robust fundamentals and analyst support suggest upside potential, but risks include earnings volatility, competitive pressures, and geopolitical factors affecting sentiment. The stock's valuation at a P/E of 41.61 requires sustained growth to justify current levels, making execution critical for future performance.

10X Genomics Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sea Limited

Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.

Read more on SE

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG